Achmea Investment Management B.V. cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 34.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,715 shares of the medical equipment provider’s stock after selling 4,578 shares during the quarter. Achmea Investment Management B.V.’s holdings in Intuitive Surgical were worth $5,001,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Adviser Investments LLC acquired a new stake in shares of Intuitive Surgical in the second quarter worth approximately $115,000. Signet Financial Management LLC acquired a new stake in shares of Intuitive Surgical in the second quarter worth approximately $115,000. Arrow Financial Corp acquired a new stake in shares of Intuitive Surgical in the third quarter worth approximately $115,000. JNBA Financial Advisors acquired a new stake in shares of Intuitive Surgical in the third quarter worth approximately $115,000. Finally, Pendal Group Ltd acquired a new stake in shares of Intuitive Surgical in the third quarter worth approximately $118,000. Institutional investors and hedge funds own 84.16% of the company’s stock.
Several research firms recently issued reports on ISRG. Wells Fargo & Co raised their target price on shares of Intuitive Surgical from $575.00 to $635.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 12th. Goldman Sachs Group raised their target price on shares of Intuitive Surgical from $540.00 to $630.00 and gave the stock a “buy” rating in a research report on Friday, July 20th. Piper Jaffray Companies raised shares of Intuitive Surgical from a “neutral” rating to an “overweight” rating and set a $600.00 target price on the stock in a research report on Tuesday, October 9th. BidaskClub cut shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 22nd. Finally, Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $582.00 target price on the stock in a research report on Tuesday, July 24th. One research analyst has rated the stock with a sell rating, four have given a hold rating and seventeen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $554.64.
Shares of ISRG stock opened at $532.56 on Friday. The company has a market cap of $59.35 billion, a price-to-earnings ratio of 74.07, a price-to-earnings-growth ratio of 3.49 and a beta of 1.02. Intuitive Surgical, Inc. has a fifty-two week low of $359.75 and a fifty-two week high of $581.12.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 earnings per share for the quarter, beating analysts’ consensus estimates of $2.66 by $0.17. The firm had revenue of $920.90 million for the quarter, compared to analysts’ expectations of $916.22 million. Intuitive Surgical had a net margin of 22.31% and a return on equity of 18.79%. Intuitive Surgical’s revenue was up 14.0% compared to the same quarter last year. During the same period in the previous year, the company posted $2.77 earnings per share. Equities research analysts predict that Intuitive Surgical, Inc. will post 9.52 EPS for the current year.
In other Intuitive Surgical news, Director Mark J. Rubash sold 150 shares of Intuitive Surgical stock in a transaction that occurred on Monday, August 27th. The shares were sold at an average price of $543.66, for a total transaction of $81,549.00. Following the transaction, the director now directly owns 4,116 shares of the company’s stock, valued at $2,237,704.56. The sale was disclosed in a filing with the SEC, which is available at this link. Also, VP Jamie Samath sold 864 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 23rd. The shares were sold at an average price of $499.21, for a total transaction of $431,317.44. Following the transaction, the vice president now directly owns 257 shares in the company, valued at $128,296.97. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 47,311 shares of company stock worth $24,144,846. 2.20% of the stock is currently owned by corporate insiders.
Intuitive Surgical Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Recommended Story: Leveraged Buyout (LBO) Explained
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.